Sandbox g55: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi- (talk | contribs) mNo edit summary |
Gerald Chi- (talk | contribs) mNo edit summary |
||
| Line 2: | Line 2: | ||
{{PBI|Enterobacter}} | {{PBI|Enterobacter}} | ||
:* '''Enterobacter species including E. aerogenes and E. cloacae''' | :* '''Enterobacter species including E. aerogenes and E. cloacae''' | ||
::* 1. '''Non–life-threatening infections or < 20% | ::* 1. '''Non–life-threatening infections or MDR-GNB prevalence < 20%''' | ||
:::* 1.1 '''Empiric antimicrobial therapy''' | :::* 1.1 '''Empiric antimicrobial therapy''' | ||
::::* Preferred regimen: [[Piperacillin-Tazobactam]] 3.375 mg IV q6h | ::::* Preferred regimen: [[Piperacillin-Tazobactam]] 3.375 mg IV q6h | ||
Revision as of 03:20, 22 July 2015
- Enterobacter
Return to Top
- Enterobacter species including E. aerogenes and E. cloacae
- 1. Non–life-threatening infections or MDR-GNB prevalence < 20%
- 1.1 Empiric antimicrobial therapy
- Preferred regimen: Piperacillin-Tazobactam 3.375 mg IV q6h
- Alternative regimen: Ciprofloxacin 400 mg IV q12h
- Acanthamoeba
Return to Top
- Acanthamoeba species
- Balamuthia mandrillaris
Return to Top
- Balamuthia mandrillaris